Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: J Psychiatr Res. 2010 May 20;45(1):83–91. doi: 10.1016/j.jpsychires.2010.04.018

Table 5.

Associations between Key Cannabis-Related Variables of the LSUR and LSUR-12 and Hypothesized Validating Measures

Cannabis-Related Variables, Sample Sizes Used for Hypothesis Tests, and Descriptive Statisticse Expected Medium-to-Large Effect Size Expected Small-to-Medium Effect Size
RETROSUB a Brief DAST b SCIDc Cannabis Use Disorder Number of Past Incarcerations NEO-FFI d Neuroticism NEO-FFI d Conscientiousness
Age at onset of daily cannabis use (16.8±2.8) N/A N/A t=1.83
p=.080 (d=.731)
n=27
ρ=−.022
p=.911
n=29
ρ=−.462
p=.018
n=26
ρ=.219
p=.283
n=26
Lifetime cannabis dose (5,141±13,225) ρ=.486
p=.001
n=43
ρ=.551
p<.001
n=50
U=153.0
p<.001 (θ=.210)
n=54
ρ=.597
p<.001
n=58
ρ=.199
p=.167
n=50
ρ=−.176
p=.223
n=50
Cannabis-related problem behaviors (4.5±6.1) N/A ρ=.681
p<.001
n=54
U=209.0
p=.017 (θ=.310)
n=52
ρ=.428
p=.001
n=56
ρ=.157
p=.285
n=48
ρ=−.241
p=.099
n=48
Past 12-week cannabis dose (105±227) ρ=.634
p<.001
n=45
N/A N/A N/A ρ=.109
p=.445
n=51
ρ=−.015
p=.917
n=51
a

Retrospective Use of Alcohol and Other Substances

b

The Drug Abuse Screening Test, Brief Version

c

Structured Clinical Interview for DSM-IV Axis I Disorders

d

Neuroticism, Extraversion, Openness Five-Factor Inventory

e

Mean and standard deviation